2019

Recently, the Administration announced it was withdrawing a controversial plan to ban drugmaker rebates to pharmacy benefit…

Pharmaceutical industry price transparency has been a hot topic since even before the 2016 presidential election. Now, just over…

In early August 2019, the Canadian government announced regulations to reduce patented drug prices, with the intent to save…

This summer has been the summer of reimportation with the Trump administration proposing pathways for national reimportation.  The…

The United States Attorney’s Office for the Southern District of New York recently announced that the United States has filed a…

The Trump administration is continuing the push for hospitals to disclose to patients how much they charge for all supplies, tests…

On July 1, 2019, Connecticut Governor Ned Lamont signed into law a bill relating to continuing medical education (“CME”)…

As we previously reported, the House Energy and Commerce Health Subcommittee held a hearing on May 21, 2019 on improving drug…

The Centers for Medicare and Medicaid Services (CMS) requires each State Medicaid Program to submit to CMS an annual report on the…

Health Canada recently published a draft guidance document, “The Distinction Between Promotion and Non-Promotional Messages and…